Literature DB >> 19449244

Extending the administration time of the letter fluency test increases sensitivity to cognitive status in aging.

Roee Holtzer1, Yelena Goldin, Peter J Donovick.   

Abstract

The authors examined whether extending the administration time of letter fluency from 1 minute per letter trial (standard administration) to 2 minutes increased the sensitivity of this test to cognitive status in aging. Participants (mean age = 84.6) were assigned to cognitive impairment (n = 20) and control (n = 40) groups. Pearson correlations and scatter plot analyses showed that associations between the Dementia Rating Scale scores and letter fluency were higher and less variable when performance on the latter was extended to 2 minutes. Analysis of variance (ANOVA) showed that the cognitive impairment group generated fewer words in the second minute of the letter fluency task compared to the control group. Finally, discriminant function analyses revealed that extending the letter fluency trials to 2 minutes increased discrimination between the control and cognitive impairment groups.

Entities:  

Mesh:

Year:  2009        PMID: 19449244      PMCID: PMC2832286          DOI: 10.1080/03610730902922119

Source DB:  PubMed          Journal:  Exp Aging Res        ISSN: 0361-073X            Impact factor:   1.645


  20 in total

1.  Verbal fluency activates the left medial temporal lobe: a functional magnetic resonance imaging study.

Authors:  M Pihlajamäki; H Tanila; T Hänninen; M Könönen; M Laakso; K Partanen; H Soininen; H J Aronen
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

2.  Frontotemporal dementia progresses to death faster than Alzheimer disease.

Authors:  E D Roberson; J H Hesse; K D Rose; H Slama; J K Johnson; K Yaffe; M S Forman; C A Miller; J Q Trojanowski; J H Kramer; B L Miller
Journal:  Neurology       Date:  2005-09-13       Impact factor: 9.910

3.  Working memory impairments in traumatic brain injury: evidence from a dual-task paradigm.

Authors:  S McDowell; J Whyte; M D'Esposito
Journal:  Neuropsychologia       Date:  1997-10       Impact factor: 3.139

4.  Brief screening tests for the diagnosis of dementia: comparison with the mini-mental state exam.

Authors:  Sandy Kilada; Alyssa Gamaldo; Elizabeth A Grant; Abhay Moghekar; John C Morris; Richard J O'Brien
Journal:  Alzheimer Dis Assoc Disord       Date:  2005 Jan-Mar       Impact factor: 2.703

5.  FMRI of the prefrontal cortex during overt verbal fluency.

Authors:  E A Phelps; F Hyder; A M Blamire; R G Shulman
Journal:  Neuroreport       Date:  1997-01-20       Impact factor: 1.837

6.  Decline in cognitive and functional skills increases mortality risk in nondemented elderly.

Authors:  N Schupf; M-X Tang; S M Albert; R Costa; H Andrews; J H Lee; R Mayeux
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

7.  The sensitivity of dual-task performance to cognitive status in aging.

Authors:  Roee Holtzer; Richard G Burright; Peter J Donovick
Journal:  J Int Neuropsychol Soc       Date:  2004-03       Impact factor: 2.892

8.  Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals.

Authors:  Dorene M Rentz; Terri J Huh; Robert R Faust; Andrew E Budson; Leonard F M Scinto; Reisa A Sperling; Kirk R Daffner
Journal:  Neuropsychology       Date:  2004-01       Impact factor: 3.295

9.  Psychometrically matched measures of global cognition, memory, and executive function for assessment of cognitive decline in older persons.

Authors:  Dan Mungas; Bruce R Reed; Joel H Kramer
Journal:  Neuropsychology       Date:  2003-07       Impact factor: 3.295

10.  Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia.

Authors:  S J Duff Canning; L Leach; D Stuss; L Ngo; S E Black
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

View more
  1 in total

1.  Recurrent perseverations on semantic verbal fluency tasks as an early marker of cognitive impairment.

Authors:  Serguei V S Pakhomov; Lynn E Eberly; David S Knopman
Journal:  J Clin Exp Neuropsychol       Date:  2018-03-04       Impact factor: 2.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.